
Metormin G 1mg/500mg Tablet SR
Marketer
Serwina Pharmaceuticals Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Metormin G 1mg/500mg Tablet SR
GlucoMet XR 1mg/500mg extended-release tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. GlucoMet XR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan that includes a balanced diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms – sweating, dizziness, headache, trembling – and appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be conducted under your physician's guidance.
Primary Ingredients of Metormin G 1mg/500mg Tablet SR
No text was provided to rewrite.
Uses of Metormin G 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metormin G 1mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metormin G 1mg/500mg Extended-Release tablet should be taken with a meal.
Common Side effects of Metormin G 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Metormin G 1mg/500mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metormin G 1mg/500mg Extended-Release tablets with food.
How Metormin G 1mg/500mg Tablet SR works:
The extended-release tablet, Metformin G 1mg/500mg SR, unites glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Metformin 1mg/500mg extended-release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release metformin 1mg/500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Extended-release metformin 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should use Metformin 1mg/500mg extended-release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Metformin G 1mg/500mg extended-release tablets cautiously. Dosage modification of Metformin G 1mg/500mg extended-release tablets may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Metformin G 1mg/500mg extended-release tablets are typically initiated at a low dose; however, it's contraindicated in patients with severe liver disease.
What if you forget to take Metormin G 1mg/500mg Tablet SR :
Should you forget a Metformin G 1mg/500mg extended-release tablet, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Metormin G 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
